Archives
Streptavidin-FITC for Mechanistic Assay Design
2026-09-16
Streptavidin-FITC can do more than reveal biotin: it can help separate molecular localization, cellular uptake, and functional delivery. This guide explains how to use fluorescein isothiocyanate conjugated streptavidin in mechanistically rigorous imaging, flow cytometry, and LNP-related workflows.
Entinostat (MS-275) Workflow for Cancer Research
2026-09-16
Build more informative Entinostat assays by separating growth arrest from cell killing and pairing viability with target-engagement measurements. This workflow connects HDAC1/3-focused pharmacology with cancer cell proliferation inhibition, retinoblastoma treatment research, and translational study design.
Dasatinib (BMS-354825) Research Workflows
2026-09-15
Build reproducible Src and Bcr-Abl signaling experiments with Dasatinib (BMS-354825), from phosphoprotein target engagement to migration and metastasis assays. This workflow also shows how to use the compound as a mechanistic comparator when studying EMT, cancer stem cell-like states, and the SNAI1–PIK3R2/p-EphA2 axis.
o-Agatoxin IVA and Excitotoxicity in Cortical Cultures
2026-09-15
Lustig, Ahern, and Greenberg tested whether blocking P- and Q-type voltage-gated calcium channels with ω-agatoxin IVA could protect cortical neurons from several excitotoxic insults. The study found no reduction in neuronal injury, showing that inhibition of presynaptic glutamate release does not necessarily translate into protection from downstream excitotoxic cell death.
Veratridine Workflows for Sodium Channel Assays
2026-09-14
Veratridine provides a controllable depolarization trigger for sodium channel dynamics research, excitotoxicity studies, and blocker screening. Its value also extends to chamber-specific cardiac models, where carefully validated right ventricular-like cardiomyocytes can reveal differences that mixed hPSC-cardiomyocyte populations obscure.
Carvedilol Phosphate: A New Lens on Hepatic IRI
2026-09-14
A translational framework for using Carvedilol Phosphate to interrogate adrenergic GPCR signaling, hepatocyte–macrophage crosstalk, and Arrb2-linked mechanisms in hepatic ischemia–reperfusion injury research.
Mifepristone (RU486) Workflows for Cancer Research
2026-09-13
Mifepristone (RU486) combines progesterone receptor blockade with a practical dose range for cancer, reproductive, and receptor-context experiments. This guide translates receptor heterogeneity into better controls, dose–response workflows, and troubleshooting decisions without overstating what the evidence proves.
DAPT in Hepatobiliary Organoid Research
2026-09-12
DAPT (GSI-IX) can turn hiPSC-derived hepatobiliary organoids into a mechanistic test system for γ-secretase and Notch signaling. This article connects staged organoid differentiation with causal pathway perturbation, functional readouts, formulation controls, and translational limitations.
U 46619: Designing Better TP-Receptor Assays
2026-09-12
U 46619, also known as 11,9 epoxymethano-prostaglandin H2, is a powerful tool for resolving the timing of TP-receptor signaling. This guide connects its platelet and vascular pharmacology with endpoint selection, dose interpretation, and translational assay design.
MK-0812: A Translational Lens on CCR2 in MASH
2026-09-11
A thought-leadership framework for using MK-0812 to test whether CCR2-dependent monocyte recruitment links intestinal TM6SF2 deficiency, gut–liver dysfunction, and hepatic inflammation in MASH models.
Verapamil HCl: Calcium Channel Research Guide
2026-09-11
Verapamil HCl is a phenylalkylamine L-type calcium channel blocker used to investigate calcium signaling, apoptosis, inflammation, and bone remodeling. Product data and a peer-reviewed osteoporosis study support defined handling conditions and mechanistic research applications, while cell and animal findings should not be interpreted as clinical efficacy.
NVP-BGJ398 Phosphate: FGFR Signal to Phenotype
2026-09-10
NVP-BGJ398 phosphate provides a mechanistic bridge between FGFR1–3 biology, biomarker-led oncology, and emerging skeletal-disease research. This thought-leadership perspective explains how to translate receptor inhibition into defensible experimental decisions while distinguishing promising preclinical signals from clinical evidence.
ABT-199: Designing Senescence-Aware Apoptosis Assays
2026-09-10
ABT-199 and Venetoclax can reveal BCL-2 dependence, but response timing is as important as concentration. This guide translates glioblastoma senescence findings into more discriminating apoptosis assay and hematologic malignancy research workflows.
Cabazitaxel (XRP6258) Workflow Guide
2026-09-09
Cabazitaxel (XRP6258) is a semi-synthetic taxane derivative for studying microtubule dynamics disruption in taxane-resistant, including P-glycoprotein-expressing, cancer models. This guide covers DMSO- or ethanol-based preparation, storage, 96-hour assay planning, and quality control; it should not be treated as a water-soluble reagent or as a substitute for paper-specific dosing or clinical guidance.
DRB for Transcriptional Elongation Workflows
2026-09-09
DRB provides an acute, tunable way to interrogate RNA polymerase II output, CDK-dependent transcription, and transcription-linked cell-fate transitions. Its value is greatest when paired with time-resolved RNA, protein, and condensate measurements rather than used as a pathway-specific readout alone.
577 records 6/39 page Previous Next First page 上5页 678910 下5页 Last page